TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of ROCK2More data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 0.900nMAssay Description:Inhibition of ROCK2More data for this Ligand-Target Pair
TargetRho-associated protein kinase 1(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 1(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: <4nMAssay Description:Inhibition of ROCK2 assessed as myosin light chain phosphorylation by cell-based assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: <6nMAssay Description:Inhibition of ROCK2 assessed as myosin light chain phosphorylation by cell-based assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of ROCK2 assessed as myosin light chain phosphorylation by cell-based assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 1(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 247nMAssay Description:Inhibition of MRCKalphaMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 365nMAssay Description:Inhibition of ROCK2 assessed as myosin light chain phosphorylation by cell-based assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 365nMAssay Description:Inhibition of ROCK2 assessed as myosin light chain phosphorylation by cell-based assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 455nMAssay Description:Inhibition of ROCK2 assessed as myosin light chain phosphorylation by cell-based assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 871nMAssay Description:Inhibition of ROCK2 assessed as myosin light chain phosphorylation by cell-based assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of ROCK2More data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.24E+3nMAssay Description:Inhibition of ROCK2 assessed as myosin light chain phosphorylation by cell-based assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.49E+3nMAssay Description:Inhibition of ROCK2 assessed as myosin light chain phosphorylation by cell-based assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.49E+3nMAssay Description:Inhibition of ROCK2 assessed as myosin light chain phosphorylation by cell-based assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibition of ROCK2 assessed as myosin light chain phosphorylation by cell-based assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.55E+3nMAssay Description:Inhibition of ROCK2 assessed as myosin light chain phosphorylation by cell-based assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: >2.70E+3nMAssay Description:Inhibition of ROCK2 assessed as myosin light chain phosphorylation by cell-based assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: >2.70E+3nMAssay Description:Inhibition of ROCK2 assessed as myosin light chain phosphorylation by cell-based assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: >2.70E+3nMAssay Description:Inhibition of ROCK2 assessed as myosin light chain phosphorylation by cell-based assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: >2.70E+3nMAssay Description:Inhibition of ROCK2 assessed as myosin light chain phosphorylation by cell-based assayMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 5.46E+3nMAssay Description:Inhibition of JNK3More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 7.86E+3nMAssay Description:Inhibition of MRCKalphaMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute And Department Of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 9.55E+3nMAssay Description:Inhibition of MRCKalphaMore data for this Ligand-Target Pair